| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.001 |